Calls
At ECRIN, we can provide support to investigators in preparing proposals for multinational clinical study funding, provided the project meets ECRIN’s eligibility criteria.
For more information on how ECRIN can support you in the preparation of these calls, see Clinical Trials Preparation and contact your local European Correspondent.
For more information and guidance on Horizon Europe funding schemes and opportunities, you are encouraged to contact your National Contact Point (NCP). Additional details on funding opportunities and events under Cluster 1 – Health are also available on the HNN3 network website, which brings together NCPs in the health area.
The calls listed below may be relevant for your applications for clinical trials / clinical research in various fields. In the News section of our website, you can also find additional information on calls on diverse topics other than clinical trials.
Discover the European funding programs for multinational clinical trials.
Call Launch :
Deadline :
Deadline 2 :
Description :
IHI call 11 is a two-stage call with topics on brain dysfunction, the link between infections and non-communicable diseases, pharmacovigilance, type 1 diabetes, and ambulatory surgical centres.
Key dates and deadlines
- Draft topic texts published: 10 April, updated 23 May
- Call launch: 17 June 2025
- Short proposal submission deadline: 9 October 2025 at 17:00 Brussels time
- Full proposal submission deadline: 29 April 2026 at 17:00 Brussels time
Other useful information
Call ID: HORIZON-JU-IHI-2025-11-two-stage | Action type: RIA - Research and Innovation Actions | Call type: Two-stage
Links :
Call Launch :
Deadline :
Deadline 2 :
Description :
EP PerMed Research Innovation and Technology Call (RITC) 2026
The European Partnership for Personalised Medicine, EP PerMed supported by the European Union under Horizon Europe, Grant Agreement N° 101137129, has launched its first research, innovation and technology call (RITC2026) for proposals on “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine”, acronym “MultiPMData2026”. In total, 19 funding organisations participate in this call with an available budget of over 14.8 Mio. € (approx.).
EP PerMed funding organisations, listed below, have agreed to jointly fund multinational innovative research and technology projects in personalised medicine (PM) to encourage innovative, interdisciplinary public-private partnerships and to support the translational and clinical implementation of research outcomes.
The call will be implemented in two stages: a pre and a full proposal phase.
Expected timeline of the call
- 1 October 2025: Publication of the call
- 28 October 2025: RITC2026 Information Day – online webinar
- 18 November 2025: RITC2026 Matchmaking Event – online event
- 12 January 2026 (14:00, CET): Deadline for pre-proposal submission
- Expected around 19 March 2026: Communication of the results of the pre-proposal assessment and invitation to the full proposal stage
- 27 April 2026 (14:00, CEST): Deadline for full-proposal submission
- End of June 2026: Rebuttal stage
- Expected for beginning of September 2026: Communication of the funding decisions to the applicants
- End of 2026, beginning of 2027: 6-months starting phase (development of Consortium Agreement, Data Management Plan and Ethics Approvals).
Expected scientific project start. Establishment of funding contracts with funding organisations (according to regional/national funding regulations).
Links :
Call Launch :
Deadline :
Deadline 2 :
Description :
Advancing knowledge on the impacts of micro- and nanoplastics on human health
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Living and working in a health-promoting environment”. To that end, proposals under this topic should aim to deliver results that are directed, tailored and contributing to most of the following expected outcomes:
- Environmental and health policies reducing exposure to micro- and nanoplastics and preventing their potential health impacts are supported with up-to-date scientific evidence, standards, tools and methodologies;
Public authorities and the scientific community have access to FAIR[1] data on realistic human exposures to micro- and nanoplastics and their potential impacts on human health based on real-world scenarios across living and working environments; - Citizens are informed about the impacts of exposure to micro- and nanoplastics on health and adopt behaviours protecting health and reducing human impacts on the environment;
Industry is supported in the assessment of products’ safety and sustainability; - Existing major knowledge gaps in the understanding of the health impacts of exposure to micro- and nanoplastics are filled and mitigation measures based on robust evidence are promoted;
- Public authorities and regulators are supported with evidence-based guidance to design health policies.
Please note that the first deadline has now passed and the second closed 16 April 2026 17:00:00 Brussels time.
Links :
Call Launch :
Deadline :
Deadline 2 :
Description :
Improving the quality of life of persons with intellectual disabilities and their families
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Living and working in a health-promoting environment”. To that end, proposals under this topic should aim to deliver results that are directed, tailored and contributing to most of the following expected outcomes:
- Global and EU policies preventing and reducing the health impacts of pollution are supported with up-to-date scientific evidence, tools and methodologies;
- Citizens are more protected by having a better insight into exposure to pollution and its impacts on brain health and adopting health enhancing behaviours;
- Public authorities, health stakeholders, the scientific community and the society at large have access to FAIR[1] data on the link between pollution and brain health, particular windows of susceptibility to exposure and the impacts of pollution on the general population and vulnerable groups;
- Public authorities develop adequate evidence-based measures and guidelines to prevent and reduce the negative impacts of pollution in the development of brain disease.
Please note that the first deadline has now passed and the second closed 16 April 2026 17:00:00 Brussels time.
Links :
Call Launch :
Deadline :
Deadline 2 :
Description :
IHI call 10 - a standard, two-stage call
IHI call 10 will be a standard, two-stage call for proposals with the following topics
- Digital label: one source of comprehensive information for medical technology products
- Enabling and safeguarding innovation in secondary use of health data in the European Health Data Space (EHDS)
- Per- and Poly-fluoroalkyl substance (PFAS) exposure, emissions, and end of life management in the healthcare sector
Read the full call text:
Links :